PLEASANTON, Calif., April 02, 2020 (GLOBE NEWSWIRE) -- 10x Genomics, Inc. (TXG) today announced the appointment of Kim Popovits, former Chairman of the Board, President and Chief Executive Officer o
Former Genomic Health CEO brings decades of healthcare experience to Board
Exact Sciences (NASDAQ:EXAS) initiated with an Outperform rating and a $70 (25% upside) price target at Evercore ISI.Health Catalyst (NASDAQ:HCAT) initiated with a Buy rating and a $40 (47% upside) pr
Exact Sciences Corp. (NASDAQ: EXAS) today announced it would be devoting significant patient education resources toward the ability to request Cologuard® online through a telehealth provider. During
EXACT Sciences Co. (NASDAQ:EXAS) – Equities researchers at SVB Leerink cut their FY2022 earnings per share (EPS) estimates for EXACT Sciences in a report released on Monday, March 30th. SVB Leerink
S&P Biotech ETF (XBI) slumped -20% year-to-date, in-line with the S&P 500, due to the unrelenting coronavirus pandemic,. Heavy exposure to small caps contribute
Brinker Capital Inc. lifted its position in shares of EXACT Sciences Co. (NASDAQ:EXAS) by 13.7% in the fourth quarter, according to the company in its most recent disclosure with the Securities and Ex
Belpointe Asset Management LLC purchased a new position in EXACT Sciences Co. (NASDAQ:EXAS) in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange C
Axa cut its stake in EXACT Sciences Co. (NASDAQ:EXAS) by 1.5% in the fourth quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned
Advisors Asset Management Inc. grew its position in EXACT Sciences Co. (NASDAQ:EXAS) by 119.7% in the 4th quarter, HoldingsChannel.com reports. The institutional investor owned 17,418 shares of the me
TheStreet downgraded shares of EXACT Sciences (NASDAQ:EXAS) from a c- rating to a d+ rating in a research report released on Tuesday morning, TheStreetRatingsTable reports. Other equities research ana
The Texas oil industry is in a state of panic, and a lot of companies are likely to go out of business at current oil prices
Exact Sciences (EXAS) closed at $60.89 in the latest trading session, marking a -0.56% move from the prior day.
Exact Sciences (EXAS) closed at $60.89 in the latest trading session, marking a -0.56% move from the prior day.
Madison-based biotechnology company Promega Corp. is working on producing reagent materials needed in testing for COVID-19.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE